Literature DB >> 8130865

Maximizing the stability of oxygen delivered via nasal cannula.

D A Benaron1, W E Benitz.   

Abstract

BACKGROUND: The effective fractional inspired oxygen concentration (FiO2) of supplemental oxygen provided to infants via nasal cannula may be adjusted by changing cannula flow rate or oxygen concentration, factors within our control. However, FiO2 also varies with changes in the patient's breathing, factors beyond our control. While a stable oxygen delivery is desirable, combinations of flow and concentration that maximize stability over time need to be studied.
OBJECTIVE: To assess the impact of different weaning strategies on the stability of inspired oxygen concentrations delivered to infants via nasal cannulas and to identify optimum strategies maximizing that stability.
DESIGN: Theoretical analysis and comparison with previously published measurements.
METHODS: We derived equations predicting the FiO2 delivered to infants via nasal cannula, incorporating traditional adjustments of cannula flow rate and oxygen concentration, as well as considering the impact of the infant's inspiratory time, tidal volume, and fraction of nasal breathing. We compared predicted results with previously published measures and evaluated strategies to maximize oxygen delivery stability over time.
RESULTS: Predicted values correlated well with published hypopharyngeal measurements (r = .97) and were unbiased, accurate predictors of FiO2. Effective FiO2 was least likely to be affected by changes in patient-controlled controlled factors when the nasal cannula flow rate was as low as possible.
CONCLUSIONS: To minimize variability in oxygen delivery via nasal cannula to infants, cannula flow should be reduced to the lowest possible flow by using undiluted (100%) oxygen. Supplemental oxygen may then be weaned by making small reductions in cannula flow. Cannula oxygen concentration should be reduced below 100% only after the minimum calibrated flow rate is reached. Such a strategy may maximize the stability of delivered oxygen over time as well as minimize the size of changes in delivered oxygen at each step of the weaning process.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8130865     DOI: 10.1001/archpedi.1994.02170030064015

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  17 in total

1.  Azithromycin to prevent bronchopulmonary dysplasia in ureaplasma-infected preterm infants: pharmacokinetics, safety, microbial response, and clinical outcomes with a 20-milligram-per-kilogram single intravenous dose.

Authors:  Rose M Viscardi; Ahmed A Othman; Hazem E Hassan; Natalie D Eddington; Elias Abebe; Michael L Terrin; David A Kaufman; Ken B Waites
Journal:  Antimicrob Agents Chemother       Date:  2013-02-25       Impact factor: 5.191

2.  Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization.

Authors:  L Marcela Merchan; Hazem E Hassan; Michael L Terrin; Ken B Waites; David A Kaufman; Namasivayam Ambalavanan; Pamela Donohue; Susan J Dulkerian; Robert Schelonka; Laurence S Magder; Sagar Shukla; Natalie D Eddington; Rose M Viscardi
Journal:  Antimicrob Agents Chemother       Date:  2014-11-10       Impact factor: 5.191

3.  Reliability of a Noninvasive Measure of V./Q. Mismatch for Bronchopulmonary Dysplasia.

Authors:  Nicolas Bamat; Sarvin Ghavam; Yumei Liu; Sara B DeMauro; Erik A Jensen; Robin Roberts; Bradley A Yoder; Haresh Kirpalani
Journal:  Ann Am Thorac Soc       Date:  2015-05

Review 4.  Oxygen administration in infants.

Authors:  B Frey; F Shann
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-03       Impact factor: 5.747

5.  Surgical Ligation Versus Percutaneous Closure of Patent Ductus Arteriosus in Very Low-Weight Preterm Infants: Which are the Real Benefits of the Percutaneous Approach?

Authors:  A Rodríguez Ogando; I Planelles Asensio; A Rodríguez Sánchez de la Blanca; F Ballesteros Tejerizo; M Sánchez Luna; J M Gil Jaurena; C Medrano López; J L Zunzunegui Martínez
Journal:  Pediatr Cardiol       Date:  2017-11-08       Impact factor: 1.655

6.  Infants born at <29 weeks: pulmonary outcomes from a hybrid perinatal system.

Authors:  W E Truog; M F Nyp; J Taylor; L L Gratny; H Escobar; W M Manimtim; C I Lachica; A Khmour; O O Oluola; A A Oshodi; M Norberg; H Dai; E K Pallotto
Journal:  J Perinatol       Date:  2013-10-17       Impact factor: 2.521

7.  Early Neonatal Oxygen Exposure Predicts Pulmonary Morbidity and Functional Deficits at 1 Year.

Authors:  Andrew M Dylag; Hannah G Kopin; Michael A O'Reilly; Hongyue Wang; Stephanie D Davis; Clement L Ren; Gloria S Pryhuber
Journal:  J Pediatr       Date:  2020-08       Impact factor: 6.314

8.  Impact of oxygen concentration on time to resolution of spontaneous pneumothorax in term infants: a population based cohort study.

Authors:  Huma Shaireen; Yacov Rabi; Amy Metcalfe; Majeeda Kamaluddeen; Harish Amin; Albert Akierman; Abhay Lodha
Journal:  BMC Pediatr       Date:  2014-08-23       Impact factor: 2.125

9.  Early Postnatal Oxygen Exposure Predicts Choroidal Thinning in Neonates.

Authors:  Ye He; Moritz Pettenkofer; Muneeswar Gupta Nittala; Srinivas R Sadda; Irena Tsui; Alison Chu
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-07-01       Impact factor: 4.799

10.  The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25-28 weeks gestation.

Authors:  Peter A Dargaville; Camille Omar F Kamlin; Antonio G De Paoli; John B Carlin; Francesca Orsini; Roger F Soll; Peter G Davis
Journal:  BMC Pediatr       Date:  2014-08-27       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.